6.2k total citations 180 papers, 2.5k citations indexed
About
Peter Mollee is a scholar working on Hematology, Molecular Biology and Oncology.
According to data from OpenAlex, Peter Mollee has authored 180 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 91 papers in Hematology, 67 papers in Molecular Biology and 66 papers in Oncology. Recurrent topics in Peter Mollee's work include Multiple Myeloma Research and Treatments (53 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (36 papers) and Lymphoma Diagnosis and Treatment (34 papers). Peter Mollee is often cited by papers focused on Multiple Myeloma Research and Treatments (53 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (36 papers) and Lymphoma Diagnosis and Treatment (34 papers). Peter Mollee collaborates with scholars based in Australia, New Zealand and United States. Peter Mollee's co-authors include Devinder Gill, Michael Crump, Jill Tate, Kevin Song, Peter Moore, Paula Marlton, W. Phillip Law, Arnold C.T. Ng, Armand Keating and William Y.S. Wang and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.
In The Last Decade
Peter Mollee
165 papers
receiving
2.4k citations
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
This map shows the geographic impact of Peter Mollee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Mollee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Mollee more than expected).
This network shows the impact of papers produced by Peter Mollee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Mollee. The network helps show where Peter Mollee may publish in the future.
Co-authorship network of co-authors of Peter Mollee
This figure shows the co-authorship network connecting the top 25 collaborators of Peter Mollee.
A scholar is included among the top collaborators of Peter Mollee based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Peter Mollee. Peter Mollee is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Brighton, Timothy, Simon McRae, Peter Mollee, et al.. (2011). Rapid diagnosis of heparin-induced thrombocytopenia (HIT) by whole blood impedance aggregometry: results of the Australian multi centre study. Queensland's institutional digital repository (The University of Queensland). 9. 82–82.1 indexed citations
13.
Mollee, Peter. (2009). Current trends in the diagnosis, therapy and monitoring of the monoclonal gammopathies.. PubMed Central.14 indexed citations
14.
Tate, Jill, et al.. (2008). Serum free light chain assay for diagnosis and monitoring of monoclonal light-chain diseases - Analytical and clinical correlations. Clinical Chemistry. 54(6).1 indexed citations
15.
Johnson, David W., Mark Jones, Devinder Gill, et al.. (2007). Immunosuppression (IST) Can Be Safely Ceased during Chemotherapy for PTLD in Renal Transplant Patients. Queensland's institutional digital repository (The University of Queensland).1 indexed citations
16.
Trappe, Ralf Ulrich, Sylvain Choquet, Stephan Oertel, et al.. (2007). Efficacy and safety of sequential treatment with rituximab and CHOP chemotherapy in B-cell PTLD: Results of a prospective international phase II study. Queensland's institutional digital repository (The University of Queensland).1 indexed citations
17.
Mollee, Peter, Kyungchul Song, Armand Keating, Richard Tsang, & Michael Crump. (2002). Autologous stem cell transplantation (ASCT) for relapsed/refractory follicular large cell lymphoma (FLCL).. Blood. 100(11).1 indexed citations
18.
Durrant, Simon, et al.. (2001). Phase I/II study of Sm-153 lexidronam, limb irradiation and stem cell transplantation for the treatment of multiple myeloma.. Bone Marrow Transplantation. 27.1 indexed citations
19.
Williamson, J., et al.. (2001). Low dose valaciclovir for the prevention of CMV disease post allogeneic bone marrow transplantation. Bone Marrow Transplantation. 27.1 indexed citations
20.
Keating, Amy K., et al.. (2001). Prolonged engraftment and transgene expression of genetically modified autologous bone marrow stromal (mesenchymal) cells after infusion post autotransplant: A platform for cell and gene therapy.. Blood. 98(11).1 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.